SANUWAVE Health, Inc.: stock overview

SNWVNASDAQHealthcare · Surgical & Medical Instruments & Apparatus

Price

$1.82

November 13, 2026Market cap $16M

DCF calculator

What Ploutos Investor adds for SANUWAVE Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 16 fiscal years, from 2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

SANUWAVE Health had revenue of $41M over the last 12 months and net income of $4.2M, a net margin of 10.1%. Revenue grew by 61.1% a year on average over the last 5 years. At $1.82 the shares trade at a P/E of 3.8. It has net debt of $10.0M. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$16M
8.59M shares
P/E
3.8
Revenue, 12 months
$41M
+61.1% a year over 5 years
Net margin
10.1%
2025: 26.8%, above 94% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2023–2025 fiscal years

+47.0% a year over 2 years

Fiscal years in figures

SNWV's revenue, profit, cash flow and dividend with each year-end price, from 2010 to 2022, 13 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 
$16M
Enterprise value 
$26M
P/E 
3.8
EV / EBIT 
–
EV / Revenue 
0.6
P/B 
5.5
FCF yield 
16.6%
Earnings yield 
26.6%

Profitability

Gross margin 
76.2%
Operating margin 
-1.1%
Net margin 3-year median: -101.4%
10.1%
ROIC 
-2.4%
ROIC, 5-year average 
16.6%
ROE 
1,383.2%

Growth

Revenue, yearly change 
+35.0%
EPS, yearly change 
–
FCF, yearly change 
-1.6%
Revenue, average a year 
+61.1%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$6.6M
Total debt 
$18M
Of which operating leases 
$1.5M
Net debt 
$10.0M
Net debt / EBITDA 
20.0x
Interest cover 
–
Current ratio 
1.18

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+0.5%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).

Gross margin

77.1%

Above 90% of the 161 companies in its industry, and 93% of all.

Operating margin

11.2%

Above 65% of the 186 companies in its industry, and 67% of all.

Net margin

26.8%

Above 94% of the 189 companies in its industry, and 88% of all.

ROA

31.6%

Above 98% of the 190 companies in its industry, and 99% of all.

Revenue growth

35.0%

Above 93% of the 186 companies in its industry, and 91% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
SANUWAVE Health, Inc.
CIK
1417663
Exchange
NASDAQ
Industry (SIC)
3841 · Surgical & Medical Instruments & Apparatus
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
8.59M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do SANUWAVE Health's filings show?

These are SANUWAVE Health's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about SNWV

Didn't find what you were looking for?

Ask us
What is SNWV's market cap?

SANUWAVE Health, Inc.'s market cap is $16M, at a price of $1.82 on November 13, 2026 and 8.59M shares.

What is SNWV's P/E?

SNWV's P/E is 3.8, on earnings per share of -$0.21 over the last 12 months.

How much revenue does SNWV have?

SANUWAVE Health had revenue of $41M over the last 12 months. Over the last 5 years it changed by +61.1% a year on average.

Does SNWV pay a dividend?

No. SANUWAVE Health paid no regular dividend over the last 12 months.

Where do the figures come from?

From SANUWAVE Health, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.